Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
DGX
MRNA
Add up to 3 more stocks
DGX
Quest Diagnostics Incorporated
-0.45%
$237.27-1.08Delayed quote: Aug 10, 2026, 2:25 PM EDT
Market Cap
$26.19B
52W Range
$171.18 - $240.13
MRNA
Moderna, Inc.
+0.22%
$59.30+0.13Delayed quote: Aug 10, 2026, 2:25 PM EDT
Market Cap
$23.53B
52W Range
$22.28 - $85.60
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | 25.30 | N/A |
| Forward P/E | 21.30 | N/A |
| P/B Ratio | 3.55 | 3.47 |
| P/S Ratio | 2.31 | 10.52 |
| P/FCF Ratio | 21.88 | N/A |
| EV/EBITDA | 16.25 | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 33.1% | 55.4% |
| Operating Margin | 14.1% | -158.1% |
| Net Margin | 9.2% | -141.4% |
| ROE | 14.1% | -46.6% |
| ROA | 6.3% | -28.8% |
| ROIC | 8.4% | -29.7% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.59 | 2.29 |
| Quick Ratio | 1.46 | 2.18 |
| Debt/Equity | 0.85 | 0.19 |
| Interest Coverage | 5.79 | -307.40 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | 1.4% | N/A |
| Payout Ratio | 37.4% | N/A |
| Yrs of Dividend Growth | 14 | 0 |
N/A includes metrics that are structurally not meaningful for a company's sector (e.g. EV multiples, free-cash-flow ratios, and working-capital ratios for banks and insurers). Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.